Found: 61
Select item for more details and to access through your institution.
Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls.
- Published in:
- Translational Psychiatry, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41398-018-0124-8
- By:
- Publication type:
- Article
Impact of Cognitive Impairments on Health-Related Quality of Life in Schizophrenia.
- Published in:
- Brain Sciences (2076-3425), 2023, v. 13, n. 2, p. 215, doi. 10.3390/brainsci13020215
- By:
- Publication type:
- Article
Efficacy and Safety of Donepezil in Patients with Schizophrenia or Schizoaffective Disorder: Significant Placebo/Practice Effects in a 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
- Published in:
- Neuropsychopharmacology, 2008, v. 33, n. 7, p. 1217, doi. 10.1038/sj.npp.1301499
- By:
- Publication type:
- Article
Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial.
- Published in:
- Neuropsychopharmacology, 2006, v. 31, n. 9, p. 2033, doi. 10.1038/sj.npp.1301072
- By:
- Publication type:
- Article
Requisite Skills and the Meaningful Measurement of Cognition.
- Published in:
- 2020
- By:
- Publication type:
- editorial
Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Placebo Response and Practice Effects in Schizophrenia Cognition Trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cognitive Decline and Disrupted Cognitive Trajectory in Schizophrenia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Predicting Schizophrenia.
- Published in:
- 2016
- By:
- Publication type:
- editorial
Cognition and Motivation as Treatment Targets in Schizophrenia.
- Published in:
- JAMA Psychiatry, 2014, v. 71, n. 9, p. 987, doi. 10.1001/jamapsychiatry.2014.1281
- By:
- Publication type:
- Article
Schizophrenia Is a Cognitive Illness.
- Published in:
- JAMA Psychiatry, 2013, v. 70, n. 10, p. 1107, doi. 10.1001/jamapsychiatry.2013.155
- By:
- Publication type:
- Article
Validation of the Persian version of the Brief Assessment of Cognition in Schizophrenia in patients with schizophrenia and healthy controls.
- Published in:
- Psychiatry & Clinical Neurosciences, 2014, v. 68, n. 2, p. 160, doi. 10.1111/pcn.12107
- By:
- Publication type:
- Article
Comprehensive model of how reality distortion and symptoms occur in schizophrenia: Could impairment in learning-dependent predictive perception account for the manifestations of schizophrenia?
- Published in:
- Psychiatry & Clinical Neurosciences, 2011, v. 65, n. 4, p. 305, doi. 10.1111/j.1440-1819.2011.02203.x
- By:
- Publication type:
- Article
Corticolimbic brain anomalies are associated with cognitive subtypes in psychosis: A longitudinal study.
- Published in:
- European Psychiatry, 2020, v. 63, n. 1, p. 1, doi. 10.1192/j.eurpsy.2020.36
- By:
- Publication type:
- Article
Current and Emerging Technologies to Address the Placebo Response Challenge in CNS Clinical Trials: Promise, Pitfalls, and Pathways Forward.
- Published in:
- Innovations in Clinical Neuroscience, 2024, v. 21, n. 1-3, p. 19
- By:
- Publication type:
- Article
Negative Symptom Dimensions of the Positive and Negative Syndrome Scale Across Geographical Regions: Implications for Social, Linguistic, and Cultural Consistency.
- Published in:
- Innovations in Clinical Neuroscience, 2017, v. 14, n. 11/12, p. 30
- By:
- Publication type:
- Article
Using the Positive and Negative Syndrome Scale (PANSS) to Define Different Domains of Negative Symptoms: Prediction of Everyday Functioning by Impairments in Emotional Expression and Emotional Experience.
- Published in:
- Innovations in Clinical Neuroscience, 2017, v. 14, n. 11/12, p. 18
- By:
- Publication type:
- Article
Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.
- Published in:
- European Journal of Human Genetics, 2009, v. 17, n. 7, p. 946, doi. 10.1038/ejhg.2008.264
- By:
- Publication type:
- Article
A Genome-Wide Investigation of SNPs and CNVs in Schizophrenia.
- Published in:
- PLoS Genetics, 2009, v. 5, n. 2, p. 1, doi. 10.1371/journal.pgen.1000373
- By:
- Publication type:
- Article
Mediciones coprimarias funcionales para ensayos clínicos en la esquizofrenia: resultados del estudio psicométrico y de estandarización MATRICS.
- Published in:
- American Journal of Psychiatry - Edición Española, 2008, v. 11, n. 5, p. 295
- By:
- Publication type:
- Article
Batería Cognitiva de Consenso MATRICS, parte 1: selección de pruebas, fiabilidad y validez.
- Published in:
- American Journal of Psychiatry - Edición Española, 2008, v. 11, n. 5, p. 284
- By:
- Publication type:
- Article
Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia.
- Published in:
- Neuropsychopharmacology, 2011, v. 36, n. 3, p. 616, doi. 10.1038/npp.2010.193
- By:
- Publication type:
- Article
Failures in Learning-Dependent Predictive Perception as the Key Cognitive Vulnerability to Psychosis in Schizophrenia.
- Published in:
- Neuropsychopharmacology, 2011, v. 36, n. 1, p. 367, doi. 10.1038/npp.2010.153
- By:
- Publication type:
- Article
Circumstances Under Which Practice Does Not Make Perfect: A Review of the Practice Effect Literature in Schizophrenia and Its Relevance to Clinical Treatment Studies.
- Published in:
- Neuropsychopharmacology, 2010, v. 35, n. 5, p. 1053, doi. 10.1038/npp.2009.211
- By:
- Publication type:
- Article
Proof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia.
- Published in:
- Neuropsychopharmacology, 2009, v. 34, n. 8, p. 1885, doi. 10.1038/npp.2009.26
- By:
- Publication type:
- Article
Antipsychotic drugs and their effects on cognitive function: protocol for a systematic review, pairwise, and network meta-analysis.
- Published in:
- Systematic Reviews, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s13643-023-02213-5
- By:
- Publication type:
- Article
Source monitoring improvement in patients with schizophrenia receiving antipsychotic medications.
- Published in:
- Psychopharmacology, 2003, v. 169, n. 3/4, p. 383, doi. 10.1007/s00213-003-1476-0
- By:
- Publication type:
- Article
Large-Scale Network Topology Reveals Heterogeneity in Individuals With at Risk Mental State for Psychosis: Findings From the Longitudinal Youth-at-Risk Study.
- Published in:
- Cerebral Cortex, 2018, v. 28, n. 12, p. 4234, doi. 10.1093/cercor/bhx278
- By:
- Publication type:
- Article
A Subgroup Analysis of the Impact of Vortioxetine on Functional Capacity, as Measured by UPSA, in Patients with Major Depressive Disorder and Subjective Cognitive Dysfunction.
- Published in:
- International Journal of Neuropsychopharmacology, 2018, v. 21, n. 5, p. 442, doi. 10.1093/ijnp/pyy020
- By:
- Publication type:
- Article
Remote self-administration of digital cognitive tests using the Brief Assessment of Cognition: Feasibility, reliability, and sensitivity to subjective cognitive decline.
- Published in:
- Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.910896
- By:
- Publication type:
- Article
Cognitive Subtyping in Schizophrenia: A Latent Profile Analysis.
- Published in:
- Schizophrenia Bulletin, 2021, v. 47, n. 3, p. 712, doi. 10.1093/schbul/sbaa157
- By:
- Publication type:
- Article
Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.
- Published in:
- Schizophrenia Bulletin, 2019, v. 45, n. 2, p. 350, doi. 10.1093/schbul/sby049
- By:
- Publication type:
- Article
Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction.
- Published in:
- Schizophrenia Bulletin, 2018, v. 44, n. 2, p. 286, doi. 10.1093/schbul/sbx080
- By:
- Publication type:
- Article
Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder.
- Published in:
- Schizophrenia Bulletin, 2017, v. 43, n. 2, p. 397, doi. 10.1093/schbul/sbw081
- By:
- Publication type:
- Article
The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms.
- Published in:
- Schizophrenia Bulletin, 2017, v. 43, n. 1, p. 57, doi. 10.1093/schbul/sbw152
- By:
- Publication type:
- Article
Phase 2 Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) in Negative and Cognitive Symptoms of Schizophrenia.
- Published in:
- Schizophrenia Bulletin, 2016, v. 42, n. 2, p. 335, doi. 10.1093/schbul/sbv072
- By:
- Publication type:
- Article
Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia.
- Published in:
- Schizophrenia Bulletin, 2016, v. 42, n. 1, p. 19, doi. 10.1093/schbul/sbv111
- By:
- Publication type:
- Article
Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings From the Longitudinal Youth at Risk Study.
- Published in:
- Schizophrenia Bulletin, 2015, v. 41, n. 6, p. 1285, doi. 10.1093/schbul/sbv012
- By:
- Publication type:
- Article
Regressing to Prior Response Preference After Set Switching Implicates Striatal Dysfunction Across Psychotic Disorders: Findings From the B-SNIP Study.
- Published in:
- Schizophrenia Bulletin, 2015, v. 41, n. 4, p. 940, doi. 10.1093/schbul/sbu130
- By:
- Publication type:
- Article
Elevated Antisaccade Error Rate as an Intermediate Phenotype for Psychosis Across Diagnostic Categories.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Elevated Antisaccade Error Rate as an Intermediate Phenotype for Psychosis Across Diagnostic Categories.
- Published in:
- Schizophrenia Bulletin, 2014, v. 40, n. 5, p. 1011, doi. 10.1093/schbul/sbt132
- By:
- Publication type:
- Article
Altered Striatal Functional Connectivity in Subjects With an At-Risk Mental State for Psychosis.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Altered Striatal Functional Connectivity in Subjects With an At-Risk Mental State for Psychosis.
- Published in:
- Schizophrenia Bulletin, 2014, v. 40, n. 4, p. 904, doi. 10.1093/schbul/sbt093
- By:
- Publication type:
- Article
The Cognitive Assessment Interview (CAI): Reliability and Validity of a Brief Interview-Based Measure of Cognition.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
The Cognitive Assessment Interview (CAI): Reliability and Validity of a Brief Interview-Based Measure of Cognition.
- Published in:
- Schizophrenia Bulletin, 2013, v. 39, n. 3, p. 583, doi. 10.1093/schbul/sbs001
- By:
- Publication type:
- Article
Dopamine D2 Receptor Occupancy and Cognition in Schizophrenia: Analysis of the CATIE Data.
- Published in:
- Schizophrenia Bulletin, 2013, v. 39, n. 3, p. 564, doi. 10.1093/schbul/sbr189
- By:
- Publication type:
- Article
Clinical Trials of Potential Cognitive-Enhancing Drugs in Schizophrenia: What Have We Learned So Far?
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Clinical Trials of Potential Cognitive-Enhancing Drugs in Schizophrenia: What Have We Learned So Far?
- Published in:
- Schizophrenia Bulletin, 2013, v. 39, n. 2, p. 417, doi. 10.1093/schbul/sbr153
- By:
- Publication type:
- Article
The FDA-NIMH-MATRICS Guidelines for Clinical Trial Design of Cognitive-Enhancing Drugs: What Do We Know 5 Years Later?
- Published in:
- Schizophrenia Bulletin, 2011, v. 37, n. 6, p. 1209, doi. 10.1093/schbul/sbq038
- By:
- Publication type:
- Article